# Xenon Pharmaceuticals Inc.: Form 8-K, filed Mar 5, 2025

- Company: [Xenon Pharmaceuticals Inc.](/companies/xene.md) (CIK 1582313)
- Form: 8-K
- Filed: 2025-03-05
- Accepted by EDGAR: Mar 5, 2025, 21:25 ET
- Period: 2025-03-03
- Accession: 0000950170-25-033653
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1582313/000095017025033653/xene-20250303.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1582313/000095017025033653/

## Items reported

- Item 4.01: Change of auditor
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1582313/000095017025033653/xene-20250303.htm

Filed Mar 5, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-033653. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.